fda compounding semaglutide enforcement november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines FDA to Restrict Ingredients Used

In recent years, GLP-1 (glucagon-like peptide-1) receptor agonists have surged in popularity for their role in managing weight loss and metabolic health

Lancet 394, 3950

Edvardsson CE, Adermark L, Gottlieb S, Alfreji S, Emous TA, Gouda Y, Thorsell A, Vujii M, Arans C, Benrick A, Wernstedt Asterholm I, Lopez MF, Becker HC, Jerlhag E

A B12 dosage chart specific to semaglutide combinations can help with accurate dosing when using these formulations

These treatments are currently undergoing clinical trials for expanded usage in pediatric populations and to target broader cardiometabolic and liver conditions, thus rapidly expanding the treatable patient pool

Improper handling can cause your semaglutide to degrade well before the printed date